CardioFocus: CardioFocus treats first patients in OptiShot pulsed field ablation system trial
CardioFocus has treated the first patients in an investigational trial of OptiShot, its pulsed field ablation (PFA) system for treating paroxysmal atrial fibrillation (AF). The post CardioFocus treats first patients in OptiShot pulsed field ablation system trial appeared first on Medical Device Network.
Read full article »
CEO
CardioFocus is a Massachusetts-based medical device company that manufactures and supplies endoscopic ablation systems for the treatment of atrial fibrillation disorder.
Read more